Where to Buy Retatrutide Research Compound in 2026 — Verification Guide
Retatrutide (LY3437943) has become one of the most searched research peptides of 2026. As a first-in-class triple GLP-1/GIP/glucagon receptor agonist currently in Phase 3 clinical trials, it represents the most pharmacologically complex metabolic research compound available for in-vitro study. Finding a verified source with independently confirmed purity and identity — not just a vendor claiming testing — requires understanding what documentation actually means in this market.
This guide covers what to look for when sourcing retatrutide for laboratory research, how to evaluate COA documentation, what pricing looks like across the current vendor landscape, and what the verification standard should be for a compound at this level of research interest.
For in-vitro and preclinical laboratory research use only. Not for human consumption.
Why Sourcing Retatrutide Requires Extra Scrutiny
Retatrutide’s rise in research popularity has attracted significant vendor attention — and with it, significant variation in product quality. Third-party testing across multiple vendors in late 2025 and early 2026 revealed that retatrutide was among the compounds most frequently showing quality inconsistencies. One major vendor that shut down in March 2026 had retatrutide samples fail independent testing across 37 tested samples — despite years of operation and a reputation as the market’s quality standard.
The lesson for researchers is direct: retatrutide’s complexity as a triple agonist peptide makes it more difficult to synthesize at high purity than simpler single-receptor compounds. Vendor claims of purity need independent verification — not just a COA from a lab the vendor controls or pays for selectively.
What Verified Retatrutide Documentation Looks Like
Before evaluating specific vendors, researchers should understand what complete verification documentation for retatrutide looks like.
Minimum acceptable documentation:
HPLC chromatographic purity — expressed as a percentage with the analytical method stated. For retatrutide, acceptable purity for research applications is generally considered 98%+ by HPLC-UV or HPLC-UV/MS. Results below 95% indicate synthesis quality issues.
LC-MS or MALDI-TOF identity confirmation — molecular mass spectrometry confirming the compound is LY3437943 specifically, not a related peptide or degradation product. Given retatrutide’s structural complexity as a fatty-acid conjugated triple agonist, identity confirmation by mass spectrometry is non-negotiable.
Lot-specific batch number — matching the number on the vial you receive. A COA without a lot number traceable to your specific shipment is not lot-specific documentation — it is a representative or archive result.
Named, accredited testing laboratory — the specific laboratory should be identifiable, their accreditation status verifiable, and their results independently confirmable. ISO 17025 accreditation is the international standard for analytical laboratory competence.
What separates good from excellent documentation:
Beyond the minimum, the strongest verification programs add:
- Endotoxin testing (EU/mg by LAL method)
- Heavy metals screening by ICP-MS
- QR-verified COAs linking directly to the laboratory’s portal
- Public searchable database entries (Janoshik Analytical)
The difference between minimum and excellent documentation matters for research reproducibility. For cell biology research specifically, endotoxin contamination can confound results significantly.
Current Market Pricing for Retatrutide Research Compound
The retatrutide vendor landscape has changed significantly since early 2026 following multiple vendor shutdowns. Current pricing across active vendors ranges considerably:
Market range (10mg lot):
- Low end: $39.99 – $44.99
- Mid range: $55.99 – $74.99
- High end: $89.99 – $124.99
Pricing variation at this level typically reflects one of three factors: supplier sourcing costs, testing investment, or margin strategy. Vendors at the high end of this range are not necessarily offering better quality — and vendors at the low end are not necessarily cutting corners. The key is whether independent verification accompanies the pricing.
PYXAX retatrutide pricing:
- 5mg: $39.99
- 10mg: $44.99
- 20mg: $64.99
Every lot independently verified by accredited independent laboratories before listing. Lot-specific COA with QR verification published before compounds ship.
How to Evaluate a Retatrutide Vendor
Step 1 — Check the lab name: If the vendor does not name the specific laboratory that tested their retatrutide, move on. “Third-party tested” without a laboratory name is a marketing claim, not documentation.
Step 2 — Verify the lab exists and is accredited: Search the named laboratory independently. Confirm they hold ISO 17025 accreditation or equivalent. Confirm their address exists. Confirm they test peptides specifically.
Step 3 — Check the COA for lot specificity: The COA should show a batch number, a sample ID, and a test date. The batch number should appear on the vial label. If the COA has no batch number traceable to your order, it is not lot-specific documentation.
Step 4 — Try to verify the result independently: The strongest vendors use laboratories with public verification portals. ILS Laboratories COAs include QR codes linking to their portal. Janoshik Analytical results are searchable by batch number at janoshik.com. If you cannot verify the result without contacting the vendor — the verification is not independent.
Step 5 — Check the date pattern: If a vendor’s entire retatrutide catalog was tested on the same date, or within a narrow window coinciding with their launch, this signals launch testing rather than ongoing lot-specific quality control.
Step 6 — Look for endotoxin data: For cell biology research applications, ask whether endotoxin data is available. Vendors who test endotoxin per lot are providing meaningfully better documentation for in-vitro applications.
Red Flags Specific to Retatrutide Sourcing
Given retatrutide’s known synthesis complexity and the documented quality failures at multiple vendors, researchers should be particularly alert to:
Purity claims without HPLC chromatogram data: A purity percentage is more meaningful when accompanied by the chromatogram itself. Some vendors publish chromatogram images alongside the purity percentage — this allows researchers to assess peak shape and separation quality, not just accept a number.
Identity confirmation by HPLC-UV only: HPLC-UV can detect presence at the expected retention time but cannot confirm molecular mass. For a compound as structurally complex as retatrutide, LC-MS or MALDI-TOF identity confirmation is essential. “HPLC tested” without mass spectrometry identity confirmation is insufficient for retatrutide specifically.
Single-source COAs on a complex compound: For compounds with known synthesis challenges — retatrutide being one — dual laboratory verification (two independent labs testing the same lot) provides meaningfully stronger quality assurance. The concordance or discordance between two lab results on the same sample is itself informative.
PYXAX Retatrutide — Verification Standard
PYXAX supplies retatrutide as a lyophilized research compound with full independent third-party verification before listing.
Testing protocol:
- Accredited independent laboratories (ISO 17025) — including ILS Labs, Krause Analytical, and Janoshik
- Panel: HPLC purity, LC-MS identity, endotoxin (USP 85), heavy metals (ICP-MS)
- QR-verified, batch-specific COA published for every lot
- Community verification: Janoshik Analytical where applied
Pricing:
- Retatrutide 5mg: $39.99
- Retatrutide 10mg: $44.99
- Retatrutide 20mg: $64.99
Availability: Retatrutide is available in the PYXAX Core Stock catalog. COA published in the COA Library before shipping.
View PYXAX Retatrutide →
View COA Library →
Read The PYXAX Standard →
All PYXAX compounds are supplied strictly for in-vitro and preclinical laboratory research use only. Not for human consumption. Not for veterinary use. Not for diagnostic procedures. These statements have not been evaluated by the FDA. Researchers are responsible for compliance with all applicable laws and regulations governing the use of research compounds in their jurisdiction.